Pleasant-tasting, non-greasy, edible compositions, preferably in liquid form, comprising edible oil or oil-like materials, a high potency, lipid soluble sweetener, such as saccharin, and a lipid soluble flavorant, are disclosed. These compositions are particularly useful as an oral dosage form for vitamins or pharmaceutical materials; in such embodiments the edible oil-like material may consist, in whole or in part, of an oily pharmaceutical agent, such as polyol fatty acid esters having at least four fatty acid ester groups, each fatty acid having from about 8 to about 22 carbon atoms.

Patent
   4382924
Priority
Jun 25 1980
Filed
Jun 25 1980
Issued
May 10 1983
Expiry
Jun 25 2000
Assg.orig
Entity
unknown
46
13
EXPIRED
1. A liquid pharmaceutical composition in oral dosage from comprising from about 25% to about 99.9% of an edible oil or oil-like pharmaceutical agent selected from polyol fatty acid esters having at least 4 fatty acid ester groups, such fatty acid having from about 8 to about 22 carbon atoms; made more palatable by incorporating in said pharmaceutical composition from about 0.001% to about 5% of a highly potent, lipid soluble sweetener, and from about 0.1% to about 5% of a lipid soluble flavorant.
2. A composition according to claim 1 wherein the sweetener is selected from the group consisting of saccharin, alkoxy aromatics, oximes, sulfamic acids, dihydrochalcones, aspartyl malonates, succanilic acids, and mixtures thereof.
3. A composition according to claim 2 which comprises from about 0.01% to about 1% of said sweetener.
4. A composition according to claim 3 wherein the sweetener is saccharin.
5. A composition according to claim 3 which comprises from about 0.1% to about 1% of the flavorant.
6. A pharmaceutical composition according to claim 1 wherein the flavorant is a natural or artificial mint flavor.
7. A pharmaceutical composition according to claim 6 wherein said flavorant is a natural or artificial peppermint flavor.
8. A pharmaceutical composition according to claim 1 which comprises from about 0.25% to about 0.5% of the sweetener.
9. A pharmaceutical composition according to claim 8 which comprises from about 0.25% to about 0.75% of the flavorant.
10. A pharmaceutical composition according to claim 9 wherein the pharmaceutical agent is sucrose octaoleate.
11. A process for preparing an edible liquid composition according to claim 1 wherein the sweetener component is solubilized in the edible oil or oil-like material and the flavorant is subsequently added to this mixture in a manner so as not to lose the volatile components contained in said flavorant.

The present invention relates to edible compositions which, in spite of the fact that they contain large amounts of oil or oil-like materials, are highly palatable when ingested orally. These compositions are particularly useful as carriers for pharmaceutical agents.

A wide variety of oil and oil-like materials are well-known ingredients in edible products, such as foods or pharmaceuticals. These materials, however, are generally found to be extremely distasteful and difficult to swallow when taken orally. This fact would readily be confirmed by almost anyone who has had to swallow castor oil. While oil can be made relatively bland in taste through deodorization, organoleptically it is still greasy tasting, relatively viscous, and very difficult for most people to stomach. A simple, easy to prepare composition which would remove such negative taste and mouthfeel impressions would, thus, be very useful, for example, in preparing an oral dosage form of oil-like pharmaceutical agents. It has now been found that by combining a high potency lipid soluble sweetener, such as saccharin, and a flavorant with an oil or oil-like material, the resulting edible composition surprisingly does not have an oily or otherwise unpleasant mouthfeel or taste and is quite palatable when ingested orally.

Various edible oils have long been known to be usefully included in food compositions, such as in mayonnaise, various food coatings or toppings, and salad dressings. See, for example, U.S. Pat. No. 3,454,405, Beach, issued July 8, 1969; U.S. Pat. No. 3,582,336, Rasmusson, issued June 1, 1971; U.S. Pat. No. 3,743,716, Rizzi, et al., issued July 3, 1973; and U.S. Pat. No. 3,968,261, Goodman, issued July 6, 1976, all of which are incorporated herein by reference. Some of these oil-containing food compositions additionally include a wide variety of sweetener and flavor components. However, there is no recognition that the selection of a specific subgroup of sweeteners as required in the present application, can, together with lipid soluble flavorants, provide palatable compositions containing high levels of edible oils or oil-like materials.

Numerous sweeteners and flavor enhancers have also been taught in the art. See, for example, U.S. Pat. No. 3,628,970, Stephens, et al., issued Dec. 21, 1971; and U.S. Pat. No. 3,899,592, Suarez, et al., issued Aug. 12, 1975, both of which are incorporated herein by reference. While these sweeteners may be, and frequently are, used in combination with various flavorants, there is no teaching or suggestion of their use with oily materials in the type of compositions taught in the present application. Finally, French Specification No. 73-23422, Laboratoires Sandoz S.A.R.L., published Mar. 21, 1975, describes the use of mixtures of saccharin and flavorant which are incorporated in gelatin capsules in order to mask bad flavors found in certain medicine products; the formation of a palatable edible oil or oil-like material containing compositions is not involved in the invention disclosed therein.

It is, therefore, an object of the present invention to provide an edible composition containing an oil or oil-like material which is found to be palatable and pleasant when eaten.

It is a further object of the present invention to provide a palatable, easy to prepare oral delivery vehicle for oily or lipid soluble pharmaceutical agents.

The present invention relates to pleasant, non-greasy tasting edible compositions, preferably in liquid form, comprising:

(a) from about 25% to about 99.9% of an edible oil or oil-like material;

(b) from about 0.001% to about 5% of a highly potent lipid soluble sweetener; and

(c) from about 0.1% to about 5% of a lipid soluble flavorant.

In a preferred embodiment, the compositions are used as a oral dosage form of a pharmaceutical agent wherein the edible oil or oil-like material is, at least in part, a pharmaceutical agent, such as polyol fatty acid esters having at least four fatty acid ester groups, each fatty acid having from about 8 to about 22 carbon atoms. The present invention also relates to the process for making the above-described palatable compositions wherein the sweetener is solubilized in the oil or oil-like material, such as by heat and/or agitation, and the flavorant is subsequently added in a manner so as not to lose its volatile components.

The compositions of the present invention contain, in major part, an edible oil or oil-like material; thus, the compositions contain from about 25 to about 99.9%, preferably from about 50 to about 99.9%, and most preferably from about 70 to about 99.9% of the oil or oil-like material. Although the present invention is preferably formulated as a liquid, it may also be formulated as a solid (e.g., a solid shortening or margarine) by using a solid or semi-solid fat as the oil-like material. To formulate the preferred liquid execution, the oily material should be one which is liquid at room temperature. Any edible oil which meets these criteria or mixtures of such oils may be included in the compositions of the present invention; examples of such materials include, but are not limited to, vegetable oils, coconut oil, palm oil, cottonseed oil, palm kernel oil, rapeseed oil, corn oil, soybean oil, sunflower oil, and safflower oil.

In addition to such conventional edible oil materials, the oil-like component may be a pharmaceutical agent or a vitamin having an oily character. When such pharmaceutical agents are used, they are incorporated in amounts which are both safe and effective in the treatment of a particular medical condition; the determination of what such amounts are is dependent upon the particular pharmaceutical agent used and is well within the skill of those knowledgeable in the pharmaceutical arts. Preferred examples of such pharmaceutical agents are the polyol fatty acid esters having at least 4 fatty acid ester groups, each fatty acid having from about 8 to about 22 carbon atoms. These materials are known to have efficacy both as low calorie fats and as inhibitors of cholesterol absorption in the body. See, U.S. Pat. No. 3,600,186, Mattson and Volpenhein, issued Aug. 17, 1971and U.S. Pat. No. 3,954,976, Mattson and Volpenhein, issued May 4, 1976, both of which are incorporated herein by reference. Examples of such compounds include glucose tetraoleate, glucose tetrastearate, glucose tetraester of soybean oil fatty acid, mannose tetraester of tallow fatty acid, galactose tetraester of olive oil fatty acid, arabinose tetraester of cottonseed oil fatty acid, xylose tetralinoleate, galactose pentastearate, sorbitol tetraoleate, sorbitol hexaester of olive oil fatty acid, xylitol, pentapalmitate, xylitol tetraester of substantially completely hydrogenated cottonseed oil fatty acid, sucrose tetrastearate, sucrose pentastearate, sucrose hexaoleate, sucrose octaester of substantially completely hydrogenated soybean oil fatty acid, sucrose octaester of peanut oil fatty acid, erythritol tetraester of olive oil fatty acid, erythritol tetraoleate, xylitol pentaoleate, sorbitol hexaoleate, sucrose octaoleate, sucrose octaester of soybean oil fatty acid and mixtures of these compounds; sucrose octaoleate is a particularly preferred compound.

The second component of the present invention is a sweetener which is included in an amount of from about 0.001% to about 5%, preferably from about 0.01% to about 1%, and most preferably from about 0.025% to about 0.5%, of the finished composition. The sweetener component used must have a relatively high potency (i.e., at least about 50 times the sweetness of glucose) in order to be effective in the compositions of the present invention; thus, standard natural sweeteners, such as sucrose, glucose, and fructose are not operable. Further, the sweetener must have at least some degree of lipid solubility at ambient temperatures. The lipid rate of solubility of the sweetener can be increased by pulverization (e.g., to a micro-fine, less than 10 μm state) and the lipid solubility increased through the use of emulsifiers, such as mono- or di-glycerides, known in the food art. Any sweetener which meets the criteria set forth herein may be used in the compositions of the present invention. In addition, mixtures of such sweeteners may be utilized. Examples of useful sweeteners include but are not limited to, synthetic alkoxy aromatics, such as Dulcin and P-4000; synthetic oximes, such as perilartine; synthetic sulfamic acids, such as acesulfame; peptides, such as aspartyl malonates and succanilic acids; dihydro-chalcones (see U.S. Pat. No. 3,743,716, Rizzi, et al., issued July 3, 1973, incorporated herein by reference), and, most preferably, saccharin (o-benzoic sulfimide).

The final required component in the compositions of the present invention is a flavorant; these materials are included at levels of from about 0.1% to about 5%, preferably from about 0.1% to about 1%, and most preferably from about 0.25% to about 0.75%, of the finished composition. The flavorant used may be natural or synthetic, but must be lipid soluble at ambient temperatures. Single flavorants or mixtures of such flavorants may be used. Although mint flavorants, especially peppermint, are preferred, flavorants of the other general types, such as fruit flavors, or vanilla and chocolate flavors, may also be used. Specific examples of flavors which may be included in the compositions of the present invention include, but are not limited to, oil of sweet birch, oil of spearmint, oil of wintergreen, anise oil, dill oil, celery seed oil, various citrus oils, including lemon, orange, lime, tangerine and grapefruit oils, clove oil, peppermint oil, cassia, carrot seed oil, cola concentrate, ginger oil, angelica oil, vanillin, and the like.

The compositions of the present invention may also optionally contain other components conventionally found in food or pharmaceutical compositions, in their art-established levels of use. Examples of such components include binders, bulking agents, vitamins, minerals, preservatives, anti-oxidants, starches, flour, milk or milk extracts, such as milk sugar or sodium caseinate, sweeteners or flavorants not falling within the definitions given above, vegetable proteins, protein hydrosylates, microbial proteins, yeast extracts, gelatin, vegetable gums, cocoa, chocolate, food acids, colorants, and mixtures of the foregoing.

In preparing the compositions of the present invention, the sweetener is solubilized in the oil or oil-like material, such as by heat and/or agitation, and the flavorant is then added in a manner so as not to lose its volatile components. Specifically, in one method of preparation, the base oil is warmed to a temperature of from about 100° F. to about 150° F. and a small amount of sweetener is added, with agitation. The agitation and heat are continued until the sweetener is solubilized in the oil. After cooling the mixture to ambient temperature, the desired level of flavorant is added and mixed until homogeneous. When the oily material is a pharmaceutical agent, it is, of course, necessary to be certain that the warming step used in preparation of the composition will not adversely affect the pharmaceutical properties of that compound.

When using the composition of the present invention in a pharmaceutical composition, two broad approaches may be used: (1) a safe and effective amount of an oil-like pharmaceutical agent may be substituted in whole or in part for the edible oil or oil-like component; or (2) the compositions of the present invention may be formulated using conventional edible oil materials and a safe and effective amount of a lipid soluble pharmaceutical agent may be added to that finished composition.

Unless otherwise specified all percentages and ratios given herein are by weight.

The following non-limiting examples illustrate the compositions and the process for making those compositions encompassed by the present invention.

Using the procedure described below, compositions of the present invention, as given in the following table, were prepared.

______________________________________
Components and Weights (grams)
Vegetable
Formulation
Oil Peppermint
Peach
No. (Crisco®)
Saccharin Concentrate1
Flavor2
______________________________________
1 120 g 0.06 g 3 g --
2 120 0.06 2 --
3 120 0.06 1 --
4 50 0.025 -- 5 drops
______________________________________
1 A mixture of 40 g vegetable oil (Crisco® Oil, sold by The
Procter & Gamble Company, Cincinnati, Ohio) and 10 g artificial peppermin
flavor (Takasago, No. G9586(l) o/s).
2 Supplied by Edlong, natural and artificial peach flavor No. 5518
(oil soluble).

In each case, the vegetable oil component was heated to a temperature of about 140° F. and stirred. Saccharin (o-benzoic sulfimide) was pulverized manually with a mortar and pestle, to enhance it dissolution, and was added to the warm oil with continued agitation. Dissolution of the saccharin appeared complete after about 30 minutes and the mixture was allowed to cool to ambient temperature. The flavor was then added to the oil mixture with agitation which was continued until the mixture was homogeneous.

All of the compositions which included the peppermint flavoring were found to be very palatable, exhibiting a non-oily taste and mouthfeel. The peach flavored sample was also found to be palatable but had a slightly oily mouthfeel. Formulation of the compositions, described above, but without the saccharin component resulted in a composition which was not considered to be palatable, having a very oily taste and mouthfeel. A similar result was obtained when the flavorant component was not included.

When other mild fruit flavors, such as strawberry or lemon, are substituted for the peach flavor, substantially similar results are obtained. Similar results are also obtained when the saccharin is replaced, in whole or part, by Dulcin, P-4000, Perilartine, Acesulfame, dihydrochalcones, aspartyl malonates, or mixtures of these compounds.

When polyol fatty acid esters having at least 4 fatty acid groups, each fatty acid having from about 8 to about 22 carbon atoms, such as sucrose octaoleate, are substituted, either partially or completely, for the Crisco oil component in the example above, substantially similar results are found.

A larger batch of a peppermint flavor variation of the present invention was formulated as follows:

______________________________________
Component Weight (grams)
______________________________________
Vegetable Oil (Crisco®)
11,000
Flavor* 55.0
Saccharin 5.5
______________________________________
*Takasago, Artificial Peppermint Flavor, No. G9586(L) o/s.

The vegetable oil was heated, with mechanical agitation, to a temperature of about 140° F. in a stainless steel container. Saccharin, manually pulverized using a mortar and pestle, was then added to the vessel. Agitation and heating were maintained until the saccharin was fully solubilized, about 4 hours later. An inert gas purge of the vessel was maintained while the oil was warm to prevent oxidation. After cooling to room temperature, the flavoring component was added and mixed until homogeneous. The resulting composition was pleasant tasting and did not have an oily taste or mouthfeel.

Substantially similar results are obtained where the vegetable oil in the above example is replaced, in whole or in part, with corn oil, soybean oil, sunflower oil, safflower oil, cottonseed oil, palm kernel oil, rapeseed oil or mixtures of these materials.

Crosby, Thomas G., Berling, Kenneth G.

Patent Priority Assignee Title
4536410, Sep 12 1983 General Foods Corporation Dipeptide sweetener composition
4594252, Sep 11 1984 The Quaker Oats Company Method for making dipeptide sweetened ready-to-eat cereal
4597970, Oct 05 1984 Cadbury Adams USA LLC Chewing gum compositions containing novel sweetener delivery systems and method of preparation
4608263, Sep 11 1984 The Quaker Oats Company Method for making flavored dipeptide sweetened comestible
4701337, Sep 12 1983 General Foods Corporation Chocolate product containing dipeptide-cocoa butter composition
4722845, Dec 23 1986 Warner-Lambert Company Stable cinnamon-flavored chewing gum composition
4752485, Oct 05 1984 Cadbury Adams USA LLC Novel sweetener delivery systems
4789664, Dec 19 1986 The Procter & Gamble Company; Procter & Gamble Company, The Food compositions with superior blood cholesterol lowering properties
4797288, Oct 05 1984 Cadbury Adams USA LLC Novel drug delivery system
4804548, Oct 05 1984 Cadbury Adams USA LLC Novel sweetener delivery systems
4822875, Dec 17 1986 The Procter & Gamble Company Sucrose polyesters which behave like cocoa butters
4828857, Oct 05 1984 Cadbury Adams USA LLC Novel sweetener delivery systems
4835001, Sep 09 1987 The Proctor & Gamble Company; PROCTER & GAMBLE, THE, Baked goods made with sucrose fatty acid esters
4849222, Mar 24 1987 The Procter & Gamble Company; Procter & Gamble Company, The Mixtures for treating hypercholesterolemia
4880657, May 06 1987 The Procter & Gamble Company Shortening compositions containing polyol polyesters
4894233, Oct 05 1984 Cadbury Adams USA LLC Novel drug delivery system for decongestants
4894234, Oct 05 1984 Cadbury Adams USA LLC Novel drug delivery system for antiarrhythmics
4902525, Apr 14 1987 Mitsubishi Kasei Corporation Sweetener composition
4931293, Dec 23 1986 Cadbury Adams USA LLC Food acid delivery systems containing polyvinyl acetate
4933183, Oct 05 1984 Cadbury Adams USA LLC Novel drug delivery system for mineral supplements
4933190, Dec 23 1986 Cadbury Adams USA LLC Multiple encapsulated sweetener delivery system
4935242, Oct 05 1984 Cadbury Adams USA LLC Novel drug delivery system for expectorants
4942054, May 13 1987 AGRILINK FOODS, INC Process for producing low calorie foods from alkyl glycoside fatty acid polyesters
4950140, Sep 14 1987 The Procter & Gamble Company; Procter & Gamble Company, The Cookies containing psyllium
4952687, Feb 19 1986 Lever Brothers Company Fatty acid esters of sugars and sugar alcohols
4973489, May 13 1987 AGRILINK FOODS, INC NY CORPORATION Polysaccaride fatty acid polyester fat substitutes
4981698, Dec 23 1986 Cadbury Adams USA LLC Multiple encapsulated sweetener delivery system and method of preparation
5017564, Jun 03 1988 SENJU PHARMACEUTICAL CO., LTD. Solid pharmaceutical preparation and method of producing same
5041541, May 05 1988 The Procter & Gamble Company Functional sugar substituted with reduced calories
5064672, Apr 20 1989 The Procter & Gamble Company Functional sugar substitutes with reduced calories
5071975, Jul 23 1986 CONOPCO, INC Process for preparing polyol fatty acid polyesters
5095008, Sep 14 1987 The Procter & Gamble Company Cookies containing psyllium
5104797, May 05 1988 The Procter & Gamble Company Process for preparing 5-C-hydroxymethyl aldohexose-based compounds
5106967, May 05 1988 The Procter & Gamble Company Functional sugar substitutes with reduced calories
5116610, Dec 29 1987 The Procter & Gamble Company Compositions for treating hypercholesterolemia
5139797, Apr 27 1990 HUHTAMAKI FINANCE B V Stabilized sweetener compositions, chewing gum compositions containing same and methods for their preparation
5286748, Jan 05 1981 General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity
5409905, Jan 05 1981 Cure for commond cold
5424420, Oct 05 1993 Kraft Foods Holdings, Inc Method for preparing saccharide polyesters by transesterification
5440027, Oct 05 1993 Kraft Foods Holdings, Inc Method for preparing saccharide fatty acid polyesters by transesterification
5550220, May 13 1987 AGRILINK FOODS, INC NY CORPORATION Alkyl glycoside fatty acid polyester fat substitute food compositions and process to produce the same
5596085, Apr 11 1995 Kraft Foods Holdings, Inc Method for preparing polyol fatty acid polyesters by transesterification
5910317, Jan 11 1988 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
6242019, Aug 14 1997 Intercontinental Great Brands LLC Taste modified hard confectionery compositions containing functional ingredients
6753010, Mar 01 2000 Shandong Luye Phamaceutical Co., Ltd. Soft gelatin capsule containing angelica oil
7151186, Oct 15 1999 DANISCO CULTOR AMERICA, INC Method for the direct esterification of sorbitol with fatty acids
Patent Priority Assignee Title
2916416,
3454405,
3582336,
3600186,
3628970,
3743716,
3778517,
3867557,
3899592,
3968261, Jul 09 1975 Kraftco Corporation Method and composition for preparing a whipped salad dressing
4013801, Feb 13 1976 NUTRASWEET COMPANY THE Edibles sweetened with flavanones
4034083, Nov 03 1975 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
FR2241291,
///
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jun 24 1980BERLING KENNETH G PROCTER & GAMBLE COMPANY, THE, A CORP OF OHIOASSIGNMENT OF ASSIGNORS INTEREST 0038100125 pdf
Jun 24 1980CROSBY THOMAS G PROCTER & GAMBLE COMPANY, THE, A CORP OF OHIOASSIGNMENT OF ASSIGNORS INTEREST 0038100125 pdf
Jun 25 1980The Procter & Gamble Company(assignment on the face of the patent)
Date Maintenance Fee Events


Date Maintenance Schedule
May 10 19864 years fee payment window open
Nov 10 19866 months grace period start (w surcharge)
May 10 1987patent expiry (for year 4)
May 10 19892 years to revive unintentionally abandoned end. (for year 4)
May 10 19908 years fee payment window open
Nov 10 19906 months grace period start (w surcharge)
May 10 1991patent expiry (for year 8)
May 10 19932 years to revive unintentionally abandoned end. (for year 8)
May 10 199412 years fee payment window open
Nov 10 19946 months grace period start (w surcharge)
May 10 1995patent expiry (for year 12)
May 10 19972 years to revive unintentionally abandoned end. (for year 12)